What happened

SelectQuote, Inc. (NYSE: SLQT) will combine every 20 shares of its common stock into one at 11:59 p.m. Eastern Time on Nov. 16. The company says the reverse split should help it regain compliance with the New York Stock Exchange minimum stock price rule.

Shares are expected to trade on a split-adjusted basis from market open on Nov. 17 under the same SLQT symbol. Outstanding shares fall from 180,185,985 to approximately 9,009,299. Authorized shares drop from 700 million to 35 million.

Stockholders approved the amendment at the Nov. 10 annual meeting, with 102,344,986 votes for and 4,025,515 against. The board could pick any ratio from 1-for-10 to 1-for-20. The company filed the amendment with the Delaware Secretary of State on Nov. 13.

Why it matters

The split changes the share count and the per-share price, not the business. Each stockholder keeps the same percentage of the company, except where cash replaces a fractional share. Equity awards and warrants are adjusted in proportion, including their exercise prices.

OptimistFi has argued that SelectQuote re-rates only if its healthcare services expansion diversifies revenue and improves cash generation against the core commission business. The split does not test that. Its benefit is defensive. Regaining compliance protects the NYSE listing the company says it wants to keep.

CEO Tim Danker said the company expects more than $60 million in operating cash flow this year and has a commissions receivable balance above $1 billion. Those are management's statements. The split is only a capital-structure step, so OptimistFi reads the filing as mixed for the case.

What's next

Split-adjusted trading is set to begin at market open on Nov. 17. A post-split price that holds above the NYSE minimum would show the step worked. A renewed slide would leave the listing question open. Management's operating cash flow expectation is the figure to check against its later reports.

Sources checked automatically Nov 16, 2026 · Human review: none
Thesis impactSLQT: no published thesis yet.